Elevance Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	197,584	175,204	170,209	155,660	136,943
Revenue Growth (YoY)	12.77%	2.94%	9.35%	13.67%	13.36%
Cost of Revenue	169,401	147,317	141,623	129,677	113,466
Gross Profit	28,183	27,887	28,586	25,983	23,477
Selling, General & Admin	20,984	20,025	20,087	17,700	15,918
Depreciation & Amortization Expenses	628	580	885	767	441
Other Operating Expenses	20,984	20,025	20,087	17,700	15,918
Total Operating Expenses	42,596	40,630	41,059	36,167	32,277
Operating Income	-14,413	-12,743	-12,473	-10,184	-8,800
Interest Income	2,194	2,051	1,825	1,485	1,378
Interest Expense	-1,402	-1,185	-1,030	-851	-798
Other Non-Operating Income (Expense)	-653	-244	-694	-550	297
Total Non-Operating Income (Expense)	139	622	101	84	877
Pretax Income	6,710	7,904	7,715	7,600	7,995
Provision for Income Taxes	1,049	1,933	1,724	1,712	1,846
Net Income	5,662	5,980	5,987	5,894	6,158
Minority Interest in Earnings	-1	-9	4	-6	-9
Net Income to Common	5,662	5,980	5,987	5,894	6,158
Net Income Growth	-5.32%	-0.12%	1.58%	-4.29%	34.69%
Shares Outstanding (Basic)	224	232	236	240	244
Shares Outstanding (Diluted)	225	233	237	243	247
Shares Change (YoY)	-3.56%	-1.90%	-2.22%	-1.62%	-2.95%
EPS (Basic)	25.28	25.81	25.38	24.56	25.26
EPS (Diluted)	25.21	25.68	25.22	24.28	24.95
EPS Growth	-1.83%	1.82%	3.87%	-2.69%	38.77%
Free Cash Flow	3,174	4,552	6,765	7,247	7,277
Free Cash Flow Growth	-30.27%	-32.71%	-6.65%	-0.41%	-24.72%
Free Cash Flow Per Share	14.13	19.54	28.50	29.85	29.49
Dividends Per Share	6.840	6.520	5.920	5.120	4.520
Dividend Growth	4.91%	10.13%	15.63%	13.27%	18.95%
Gross Margin	14.26%	15.92%	16.79%	16.69%	17.14%
Operating Margin	-7.29%	-7.27%	-7.33%	-6.54%	-6.43%
Profit Margin	2.87%	3.41%	3.52%	3.78%	4.49%
FCF Margin	1.61%	2.60%	3.97%	4.66%	5.31%
EBITDA	-12,668	-11,197	-11,080	-8,509	-7,498
EBITDA Margin	-6.41%	-6.39%	-6.51%	-5.47%	-5.48%
EBIT	-14,413	-12,743	-12,473	-10,184	-8,800
EBIT Margin	-7.29%	-7.27%	-7.33%	-6.54%	-6.43%
Effective Tax Rate	15.63%	24.46%	22.35%	22.53%	23.09%

Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q